Update on Two Clinical Studies: GENERATION HD2 (tominersen) and POINT-HD (RG6496)katie82882 hours ago0 min read
Prilenia and Ferrer Announce Initiation of the Confirmatory PRECISE-HD Study of Pridopidine in Huntington’s Disease
HDSA 2026: Austedo’s benefits extend beyond chorea treatmentTeva Pharmaceuticals’ Austedo (deutetrabenazine) and its extended-release formulation, Austedo XR — approved to treat chorea, or involuntary movements, in people with Huntington’s disease — have funct
Comments